Initial digest — OX1R receipt

what this node claims

Initial digest — OX1R

AlphaFold v6 prediction landed for **OX1R** (Orexin receptor type 1). UniProt accession: `O43613`. Lane: `sleep_circadian`. Mean per-residue pLDDT: **78.81**. _(no notes)_

Open source surface

vertical proof spine

evidence / risk instrument

39%

thin proof

low debt pressure 29%

28%structuredebt

pLDDT pending

55%evidencethin

grade C

0%gatesdebt

0/5 gates

100%riskstrong

0 hard flags

22%exportdebt

no export

33%lineagedebt

incomplete spine

proof completeness

33% missing target, alphafold_metric, candidate, export

01 target
02 fold
03 alphafold metric
04 candidate
05 finding
06 export

Metrics and receipt inputs

confidence: 0.6
evidence refs: 1

AlphaFold metrics visual

Confident backbone model

78.8

425 residues / min 27.14 / max 98.62 / source alphafold db

Very high 54.4% 231 residues / >=90

Confident 17.2% 73 residues / 70-89

Low 9.4% 40 residues / 50-69

Very low 19.1% 81 residues / <50

usable fold context with explicit model-confidence limits

Near-complete coverage / observed 425 of 425 residues.

residues 376-425 / mean 35.62
residues 245-276 / mean 50.71
residues 1-28 / mean 45.25
residues 189-198 / mean 61.26

proof debt register

Visible limits, not hidden cleanup.

29%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

high low evidence grade attach graded finding with source-linked evidence

low computational-only status add independent evidence, challenge result, or witness review before strengthening

medium no candidate yet leave visible until a stronger public receipt resolves it

Initial digest — OX1R